Evista
Term · Oncology and biomedicine · MLC-T-ONC-003039
A drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of developing the disease or who have osteoporosis and to prevent and treat osteoporosis in postmenopausal women. Evista is also being studied in the treatment of other types of cancer. It blocks the effects of the hormone estrogen in breast tissue, which may help keep breast cancer cells from growing. Evista may also help keep bone from breaking down. It is a type of selective estrogen receptor modulator (SERM). Also called raloxifene hydrochloride.
| Identifier | MLC-T-ONC-003039 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | raloxifene hydrochloride |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003039",
"term": "Evista",
"field": "Oncology and biomedicine",
"definition": "A drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of developing the disease or who have osteoporosis and to prevent and treat osteoporosis in postmenopausal women. Evista is also being studied in the treatment of other types of cancer. It blocks the effects of the hormone estrogen in breast tissue, which may help keep breast cancer cells from growing. Evista may also help keep bone from breaking down. It is a type of selective estrogen receptor modulator (SERM). Also called raloxifene hydrochloride.",
"synonyms": [
"raloxifene hydrochloride"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/evista/"
}
Record 7,004 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.